[The evaluation of immunoinflammatory response in XXXX ].

@entity1 @entity295 @entity326 @entity1904 @entity281 @entity298 @entity1851
AIM: To evaluate the immunoinflammatory markers that shape the evolution of @entity298 and to assess their utility in specifying the development of @entity326 from @entity298 . MATERIAL AND METHOD: We conducted a prospective study on a sample of 100 @entity1 with @entity298 , hospitalized during 2001-2005 and immunologically monitored. We realized 2000 dosages of immunoinflammatory markers for 15 days by 1200 simple radial immunodiffusion tests (IDRS), the Mancini-Carbonara method for @entity1851 , complement component C3, immunoglobulins and 836 ELISA tests to evaluate cytokines. Results were reported to a witness group. RESULTS: @entity1851 ( @entity1851 ) values were significantly elevated in @entity1 with @entity298 (12-310 ng%) vs. witness group (1.5-8 ng%). Postoperative, elevated values were maintained at the @entity1 who will develop serious complications and were correlated with multiple organic dysfunction in deceased @entity1 . Determination of circulating immune complexes have shown elevated values in @entity1 with @entity298 . Dosage of pro/antiinflammatory cytokines may be specific to the severity of @entity281 . The level of @entity1904 was increased in @entity1 with @entity295 and severe inflammatory reactions and become an important prognostic tool. CONCLUSIONS: The study of biological markers in microbial aggression highlights the role of cytokines as messengers and important mediators of immunoinflammatory response. PCT test can be introduced in the daily tracking protocol for septic @entity1 .
